Academic Journal
Q1Frontiers in Pharmacology
About Frontiers in Pharmacology
Frontiers in Pharmacology is a scholarly journal published by Frontiers Media SA. SCImago 2025 places it in Q1 with an SJR of 1.248 and an H-index of 203.
Its listed coverage is 2010-2026 and its research categories include Pharmacology (Q1); Pharmacology (medical) (Q1). The 2025 dataset reports 3714 documents and 70415 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Pharmacological Effects of Natural Compounds, Computational Drug Discovery Methods, Traditional Chinese Medicine Analysis, Liver Disease Diagnosis and Treatment, Ferroptosis and cancer prognosis, Neuroscience and Neuropharmacology Research.
Recent Research Articles
Latest publications matched automatically by ISSN.
Gentiana sino-ornata Balf. f. ethyl acetate extract alleviates high-fat diet- and tetracycline-induced liver injury in mice: insights from serum pharmacochemistry, network pharmacology, and experimental validation
Mi Zhang, Zhaobin Xia, Qingyun Gu, Lincheng Ye et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1923448Editorial: Medicinal plants from the Americas: a source of biologically active extracts and metabolites
Ana H. F. Castro, John T. Arnason, Irene Villasenor, Luciana A. Lima et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1956535Vortioxetine enhances the anti-pancreatic cancer efficacy of gemcitabine through reducing MAOB expression
Mengjie Gu, Yingxue Si, Kaizhi Luo, Chong Zhang et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1856439Cloning of a novel cyanobacterial serotonin N-acetyltransferase gene CySNAT3 and its integration with transcriptomic drug repurposing in pediatric obstructive sleep-disordered breathing
Wen Wen, Fei Xu, Yaoming Xu, Yifei Gao et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1851793Optimal buprenorphine exposure to treat patients with opioid use disorder in the era of fentanyl and polysubstance use
L. R. L. Lohmer, M. K. Greenwald, R. Kakar, C. M. Laffont et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1839067Therapeutic effect of ginseng: a non-antibiotic approach to preventing pathogenic bacterial infections and restoring gut microbiota composition
Seong-Hyeon Kim, Changhan Lee
2026-09-08 · DOI: 10.3389/fphar.2026.1866260JAK inhibitors and adverse cardiovascular events: Class effect or molecule-specific risk?
Mislav Radić, Tina Bečić, Petra Šimac Prižmić, Marija Rogoznica Pavlović et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1896980Evaluation of tilapia skin (Oreochromis niloticus) frozen, frog skin (Rana catesbeiana), and tilapia skin (Oreochromis niloticus) sterilized with gamma rays dressings, in equine skin wound healing
Rachel Pereira da Rocha Miranda, Beatriz Alves de Miranda, Andressa Borges Aranha, Maria Fernanda Bruno Gomes Ramos et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1896365Artificial intelligence-enabled cross-scale integration of traditional Chinese medicine and biomedicine for sepsis: from mechanisms to delivery
Ying-ying Cai, Yi Luo, Jie Yang
2026-09-08 · DOI: 10.3389/fphar.2026.1879407PTGER4 promoter methylation may serve as an independent prognostic biomarker and is associated with response to hypomethylating agents in pediatric acute myeloid leukemia
Yu-juan Xue, Xiaoyu Cao, Yinping Yang, Yu Wang et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1922446Case report end-stage cystic fibrosis with fatal outcome in two siblings from a Chinese family: a 15-year diagnostic odyssey
Yuelin Shen, Qionghua Chen, Haiming Yang
2026-09-08 · DOI: 10.3389/fphar.2026.1894322Hippo pathway in endometriosis pathogenesis: from cellular dysregulation to therapeutic opportunities
Gizemnaz Kara, Aylin Yaba
2026-09-08 · DOI: 10.3389/fphar.2026.1897505Risk factors for drug-related cachexia: an analysis based on the FDA adverse event reporting system (FAERS) from 2004 to 2025
Lingli Huang, Shuchen Dong, Quanli Zhang, Jie Ni et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1913539Berberine as a multitarget modulator of metabolic inflammation: molecular mechanisms, circadian regulation, and translational perspectives
Jiaxuan Xie, Junbo Cao, Shuying Zhang, Jiayang Zhang et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1935151Correction: Efficacy of combined sodium-glucose cotransporter 2 inhibitors and finerenone in chronic kidney disease: a systematic review and meta-analysis
Chen-Fu Wen, Min-Hsiang Chuang, Vin-Cent Wu, Jui-Yi Chen et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1902375Risk prediction of severe chemotherapy-induced peripheral neuropathy in breast cancer patients receiving nab-paclitaxel: a clinical nomogram
Yujun Tong, Tiantian Liang, Jiangping Yu, Hong Ning et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1794696Modulation of mitochondrial quality control in sepsis by traditional Chinese medicine: mechanistic insights and translational perspectives
Maoxiao Chang, Dingji Hu, Kexin Zhang, Suxia Liu et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1865750Development and validation of a pharmacokinetic tool to convert random topiramate concentrations to standardized trough levels in bipolar disorder
Xuan Jv, Shuzhen Li, Ye Liu, Qianqian Cao et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1867058Diabetic kidney disease within the framework of cardio-kidney-metabolic health: a paradigm shift
Juarez R. Braga, Fatima Ayub, Srikanth Vallurupalli, Nithin Karakala et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1907928Hesperidin reduces genomic instability in glioblastoma cells and is associated with reduced HNRNPA2B1/m6A levels
Viktoriia Sazonova, Pavel Zun, Ilia Tonkji, Sergey Onikienko et al.
2026-09-08 · DOI: 10.3389/fphar.2026.1876112Reviews
Community Reviews
Version History
September 8, 2026 at 12:03 am
September 8, 2026